The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-(3-((5-Cyclobutylthiophen-2-yl)ethynyl)phenyl)-5-(2-cyclopropylethyl)-4-(3-fluoro-4-sulfamoylbenzyl)-1H-pyrazol-1-yl)-thiazole-4-carboxylic Acid ID: ALA4745150
PubChem CID: 139465422
Max Phase: Preclinical
Molecular Formula: C35H31FN4O4S3
Molecular Weight: 686.86
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)c1ccc(Cc2c(-c3cccc(C#Cc4ccc(C5CCC5)s4)c3)nn(-c3nc(C(=O)O)cs3)c2CCC2CC2)cc1F
Standard InChI: InChI=1S/C35H31FN4O4S3/c36-28-19-23(11-16-32(28)47(37,43)44)18-27-30(14-10-21-7-8-21)40(35-38-29(20-45-35)34(41)42)39-33(27)25-6-1-3-22(17-25)9-12-26-13-15-31(46-26)24-4-2-5-24/h1,3,6,11,13,15-17,19-21,24H,2,4-5,7-8,10,14,18H2,(H,41,42)(H2,37,43,44)
Standard InChI Key: DYNXSJAPVULPQJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
47 53 0 0 0 0 0 0 0 0999 V2000
43.3772 -17.9823 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.1944 -17.9865 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
43.7893 -17.2767 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
45.9030 -22.2128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.7202 -22.2128 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
46.9746 -21.4361 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
46.3116 -20.9539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.6529 -21.4361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.7544 -21.1813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
48.4148 -21.6625 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
49.0766 -21.1831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
48.8252 -20.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
48.0080 -20.4045 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.8756 -21.1839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.7053 -20.3846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3142 -19.8384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.1445 -19.0398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.3665 -18.7870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7580 -19.3388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.9309 -20.1354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.3104 -20.1367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.0174 -19.7271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.4224 -22.8702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6088 -22.7823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1278 -23.4420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.4591 -24.1899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.2762 -24.2743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.7536 -23.6136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
49.3064 -19.7450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
50.1190 -19.8315 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
48.9750 -18.9980 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.9798 -19.0894 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
44.8014 -17.4400 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.3152 -23.3545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.0162 -18.9099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.4231 -18.2049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.6059 -18.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5024 -23.2670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6899 -23.1795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2815 -22.4764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4817 -22.6443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3943 -23.4569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1400 -23.7910 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
39.6856 -23.8637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8985 -23.6491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6851 -24.4379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4740 -24.6514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 4 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 2 0
6 9 1 0
8 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
7 21 1 0
21 22 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
4 23 1 0
12 29 1 0
29 30 1 0
29 31 2 0
19 32 1 0
18 2 1 0
2 33 1 0
25 34 1 0
22 35 1 0
36 35 1 0
37 36 1 0
35 37 1 0
34 38 3 0
38 39 1 0
39 40 2 0
40 41 1 0
41 42 2 0
42 43 1 0
43 39 1 0
42 44 1 0
44 45 1 0
45 46 1 0
46 47 1 0
47 44 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 686.86Molecular Weight (Monoisotopic): 686.1491AlogP: 7.14#Rotatable Bonds: 10Polar Surface Area: 128.17Molecular Species: ACIDHBA: 8HBD: 2#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.17CX Basic pKa: 1.36CX LogP: 9.03CX LogD: 5.68Aromatic Rings: 5Heavy Atoms: 47QED Weighted: 0.15Np Likeness Score: -1.11
References 1. Rai G,Urban DJ,Mott BT,Hu X,Yang SM,Benavides GA,Johnson MS,Squadrito GL,Brimacombe KR,Lee TD,Cheff DM,Zhu H,Henderson MJ,Pohida K,Sulikowski GA,Dranow DM,Kabir M,Shah P,Padilha E,Tao D,Fang Y,Christov PP,Kim K,Jana S,Muttil P,Anderson T,Kunda NK,Hathaway HJ,Kusewitt DF,Oshima N,Cherukuri M,Davies DR,Norenberg JP,Sklar LA,Moore WJ,Dang CV,Stott GM,Neckers L,Flint AJ,Darley-Usmar VM,Simeonov A,Waterson AG,Jadhav A,Hall MD,Maloney DJ. (2020) Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties., 63 (19.0): [PMID:32902275 ] [10.1021/acs.jmedchem.0c00916 ]